Pneumonic Plague: The Deadliest Form

Of the three clinical forms of plague, pneumonic plague is the most rapidly fatal and the most dangerous to public health. Unlike bubonic plague, which is transmitted by flea bites, pneumonic plague spreads directly from person to person through respiratory droplets, making it capable of causing explosive outbreaks in crowded environments. Its presence during the Black Death — alongside the more common bubonic form — was a critical factor in the pandemic’s extraordinary speed and lethality.

Pathogenesis and Transmission

Pneumonic plague occurs when Yersinia pestis bacteria reach the lungs, either through secondary spread from a bubonic infection (secondary pneumonic plague) or through direct inhalation of respiratory droplets from another pneumonic patient (primary pneumonic plague).

In secondary pneumonic plague, bacteria that have multiplied in the lymph nodes during a bubonic infection enter the bloodstream and are carried to the lungs, where they establish a secondary focus of infection. This progression occurs in a minority of bubonic plague cases — perhaps ten to twenty percent — and represents a worsening of the patient’s condition.

In primary pneumonic plague, bacteria are inhaled directly from the respiratory secretions of an infected person. When a pneumonic plague patient coughs or sneezes, they expel droplets containing millions of bacteria. Anyone who inhales these droplets at close range (typically within two metres) may develop primary pneumonic plague, which progresses with terrifying speed.

The ability of pneumonic plague to spread directly between humans — without the intermediary of fleas and rodents — is what makes it so dangerous. While bubonic plague requires the rat-flea-human transmission cycle, pneumonic plague can spread through purely human-to-human transmission, creating chains of infection that can move rapidly through populations.

Symptoms and Clinical Course

The incubation period of primary pneumonic plague is extremely short — typically one to three days, and sometimes as little as a few hours. The onset of symptoms is sudden and violent. The patient develops a high fever, severe headache, chest pain, difficulty breathing, and a cough that rapidly becomes productive of bloody, frothy sputum.

The sputum of a pneumonic plague patient is highly infectious, containing enormous numbers of Yersinia pestis bacteria. The characteristic “spitting of blood” described by medieval observers — including Guy de Chauliac, who noted that the first phase of the Black Death in Avignon was characterised by “continuous fever and spitting of blood, and the sick died within three days” — is the hallmark of pneumonic plague.

Without antibiotic treatment, pneumonic plague is almost invariably fatal. Death typically occurs within one to three days of symptom onset, often before buboes have time to develop. The rapidity of the disease’s progression means that patients may die before they or their physicians recognise the nature of the illness.

Pneumonic Plague During the Black Death

The role of pneumonic plague in the Black Death has been the subject of extensive scholarly debate. The speed with which the pandemic spread across Europe — from Messina to Norway in approximately two years — exceeds what would be expected from purely flea-borne bubonic plague transmission. The involvement of pneumonic plague, which can spread directly between humans, provides the most plausible explanation for this rapidity.

Contemporary sources provide abundant evidence of pneumonic plague during the Black Death. The Sienese chronicler Agnolo di Tura described a disease that “seemed to strike through the breath and sight” — a reference to the respiratory transmission of pneumonic plague. The physician Guy de Chauliac distinguished between two phases of the epidemic in Avignon: an initial phase characterised by “spitting of blood” and death within three days (pneumonic plague), followed by a second phase characterised by buboes and death within five days (bubonic plague).

The seasonal pattern of the Black Death also supports the involvement of pneumonic plague. In several regions, the epidemic intensified during the winter months, when flea activity would normally be reduced. The persistence of transmission during cold weather is consistent with pneumonic plague, which spreads more efficiently in the cold, dry conditions of winter, when people are crowded together indoors and respiratory droplets remain viable longer in the air.

The Epidemiological Significance

The co-circulation of bubonic and pneumonic plague during the Black Death created a synergistic epidemic that was far more devastating than either form alone would have been. Bubonic plague, transmitted by fleas, established the disease in new locations and created a large pool of infected individuals. Some of these individuals developed secondary pneumonic plague, which then spread directly to their family members, neighbours, and caregivers, creating new chains of human-to-human transmission.

This pattern explains several features of the Black Death that are difficult to account for through bubonic plague alone. The speed of the pandemic’s advance, the high mortality in households and communities, the persistence of transmission during winter, and the devastating impact on isolated communities (where rat populations would have been small) are all consistent with the involvement of pneumonic plague.

The epidemiologist Ole Benedictow has argued that pneumonic plague accounted for a significant proportion of Black Death mortality, perhaps as much as twenty to thirty percent of cases in some regions. Other scholars, while acknowledging the role of pneumonic plague, have emphasised the importance of bubonic plague as the primary driver of the pandemic. The debate reflects the difficulty of reconstructing the relative contribution of different clinical forms from medieval sources, which did not distinguish between them with modern precision.

Pneumonic Plague in Modern Medicine

In the modern era, pneumonic plague remains the most dangerous form of plague. Without antibiotic treatment, the mortality rate approaches one hundred percent, and death can occur within twenty-four hours of symptom onset. Even with treatment, the mortality rate is significant — approximately fifty percent — particularly if antibiotics are not administered within the first twenty-four hours of illness.

The potential for pneumonic plague to cause explosive outbreaks remains a public health concern. In 1994, an outbreak of pneumonic plague in Surat, India, caused widespread panic and the flight of hundreds of thousands of residents from the city, though the actual number of cases and deaths was relatively small. In 2017, a major, predominantly pneumonic plague outbreak in Madagascar caused more than 2,400 cases and over 200 deaths across all forms (roughly three-quarters of cases were pneumonic), requiring an international public health response coordinated by the World Health Organization.

The modern understanding of pneumonic plague, based on bacteriology and respiratory medicine, has informed the development of infection control protocols, including the use of masks, isolation of patients, and prophylactic antibiotics for contacts. These measures, combined with prompt antibiotic treatment, have made pneumonic plague outbreaks manageable in countries with adequate public health infrastructure.